Senior Director, Head of Global S&OP & Resilience

Alexion is poised to become the global leader in rare diseases by 2027, expanding to over 100 countries and launching five new medicines by 2030. The Head of Global S&OP & Resilience will lead and optimize Global Sales & Operational Planning (S&OP) at enterprise level within AstraZeneca’s Rare Disease unit, synchronizing demand forecasts, production capabilities, and inventory to reliably meet patient and customer needs. This role shapes the long-term supply chain risk strategy, drives innovation across the end-to-end network, and partners with senior leaders to ensure our supply chain remains robust, sustainable, and ready for the future. Ready to turn complex global challenges into clear, decisive action that directly impacts people living with rare diseases?

Accountabilities
Lead the Global S&OP process across the Rare Disease enterprise, ensuring a single, aligned view of demand, supply, and inventory that supports strategic growth ambitions.
Establish, track, an...